1st Optimal Alternatives: Best Options for Every Use Case in 2025

What Is 1st Optimal and Who Is It For?

1st Optimal positions itself as a full-spectrum performance and longevity clinic delivered through telehealth. The practice operates entirely on a cash-pay basis, which means no insurance billing, no coverage disputes, and pricing that sits above average for single-condition telehealth but below a true in-person concierge practice.

The platform markets to a specific type of patient: a male or female between roughly 30 and 60 who is already health-engaged, has read about peptide stacks or testosterone optimization, and wants a physician who will work through a broad protocol rather than a narrow prescription.

What 1st Optimal Actually Prescribes

Services reported by current members include testosterone cypionate or enanthate for men, progesterone and estradiol for women, GLP-1 receptor agonists (semaglutide or tirzepatide compounded or brand-name), thyroid optimization, and growth hormone secretagogue peptides such as CJC-1295 paired with ipamorelin. Some members also report access to BPC-157 for tissue repair.

The Regulatory Wrinkle With Peptides

Prescribing peptides through telehealth sits in a complicated regulatory space. The FDA has placed several peptides, including BPC-157, on a list requiring further evaluation under 503A and 503B compounding rules [1]. Any platform prescribing these agents should be documenting a clear clinical rationale and sourcing from an FDA-registered 503B outsourcing facility. Ask any prospective clinic to confirm their pharmacy's registration status.

Is 1st Optimal Legit? An Honest Assessment

Yes, 1st Optimal is a legitimate medical practice with licensed prescribers. The concern is not legality but rather fit. No single telehealth practice excels equally at every service it offers.

Where 1st Optimal Gets It Right

The concierge model means patients typically get more face time with a provider than they would at a high-volume TRT-only clinic. Lab interpretation tends to be thorough, and the protocol-thinking (looking at testosterone, SHBG, thyroid, metabolic markers together) aligns with the Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy, which recommends evaluating the full hypothalamic-pituitary-gonadal axis rather than treating testosterone in isolation [2].

Where the Breadth Becomes a Weakness

A platform managing TRT, GLP-1, peptides, thyroid, and women's hormones simultaneously tends to produce generalist-level depth in each area. If your primary problem is obesity-driven metabolic disease, the SURMOUNT-1 trial (N=2,539) showed tirzepatide 15 mg produced 20.9% mean body-weight reduction at 72 weeks compared with 3.1% for placebo [3]. Getting that result requires a GLP-1-specialist team that understands dose titration, GI side-effect management, and muscle-mass preservation, not a performance clinic that also happens to offer semaglutide.

The same logic applies to women's hormone replacement. The Menopause Society (formerly NAMS) 2022 position statement specifies that estrogen-progestogen therapy is most effective when individualized by route, dose, and formulation [4]. A practice that runs mostly male TRT patients may not iterate on transdermal vs. Oral estradiol with the same precision as a women's health-only platform.

The Best 1st Optimal Alternative by Use Case

The alternatives below were selected based on publicly available clinical protocols, prescriber credentials, pharmacy sourcing transparency, and cost structure. None of these is a paid placement.

Use Case 1: Testosterone Replacement Therapy (Men)

Best alternative: Defy Medical (Tampa, FL, in-person + telemedicine)

Defy Medical has been operating since 2012 and focuses almost exclusively on men's hormone optimization. Their protocols typically start with total testosterone, free testosterone, SHBG, LH, FSH, estradiol (sensitive assay), complete blood count, and a lipid panel, matching the minimum diagnostic workup recommended by the Endocrine Society guideline [2].

Testosterone cypionate 200 mg/mL vials with self-injection instruction are standard. Add-ons like hCG (for testicular volume and fertility preservation) and anastrozole are available when clinically indicated.

Runner-up: Maximus

Maximus targets a younger male demographic, uses a subscription model around $129, $149/month, and publishes its clinical protocols openly. The primary difference from Defy is that Maximus is entirely asynchronous for routine follow-ups, which suits men who do not want video appointments.

Both platforms cost less per month than most reported 1st Optimal TRT pricing when the consultation fees are factored in.

Use Case 2: GLP-1 Weight Management

Best alternative: Ro Body or Found

The STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg subcutaneously once weekly produced 14.9% mean body-weight loss at 68 weeks versus 2.4% with placebo [5]. That result requires consistent weekly dosing, a structured titration schedule (starting at 0.25 mg, advancing every four weeks), and dietary co-management. GLP-1-specialist platforms have built their entire clinical workflow around exactly this.

Ro Body pairs semaglutide prescriptions with a registered dietitian program. Found includes behavioral health support. Both platforms accept insurance for some services and offer compounded semaglutide at lower cost when brand-name Wegovy or Ozempic is unaffordable.

A 2023 analysis in JAMA Network Open found that patients receiving combined pharmacotherapy plus behavioral counseling for obesity achieved 3.4 percentage points greater weight loss than those receiving medication alone [6]. Platforms built around GLP-1 are more likely to provide that counseling layer.

Note on compounded semaglutide: The FDA issued guidance in 2024 clarifying that compounded semaglutide is not FDA-approved and that the shortage status affecting exemptions should be confirmed before prescribing [1]. Any GLP-1 platform you choose should be able to confirm current compounding legality for your state.

Use Case 3: Women's Hormone Replacement Therapy

Best alternative: Midi Health or Alloy

Midi Health staffs exclusively with menopause-certified clinicians and nurse practitioners who have completed the Menopause Society's practitioner program. Alloy focuses specifically on perimenopause and postmenopause with standardized estradiol-patch and oral progesterone protocols.

The Menopause Society states: "Hormone therapy is the most effective treatment for vasomotor symptoms and has been shown to prevent bone loss and fracture" [4]. Getting that benefit requires a provider who will choose the right estradiol dose (commonly 0.05 to 0.1 mg/day transdermal) and the right progestogen (micronized progesterone 200 mg/day for 12 days/cycle or 100 mg/day continuous).

Alloy starts at approximately $75, $90/month for a basic estradiol and progesterone protocol, which is substantially below typical 1st Optimal pricing for women's hormones.

Use Case 4: Longevity Peptides and Growth Hormone Secretagogues

Best alternative: AgelessRx

AgelessRx prescribes a narrower set of better-studied longevity compounds, including low-dose naltrexone (LDN), metformin (off-label longevity use), rapamycin (off-label), and MOTS-c. The platform is more conservative about peptides like BPC-157 precisely because the evidence base is thinner.

On growth hormone secretagogues specifically: a 2019 review in the Journal of Clinical Endocrinology and Metabolism noted that sermorelin and related peptides produce modest GH pulsatility increases but that long-term safety data remain limited [7]. Any provider prescribing these should discuss that trade-off explicitly. If a clinic does not mention the evidence gap, that is a signal about their clinical standards.

For the evidence-forward longevity patient: Fountain Life

Fountain Life operates a diagnostics-first model. Before prescribing anything, they run full-body MRI, coronary artery calcium scoring, advanced lipid panels, and continuous glucose monitoring. The cost is high (membership starts near $3,500/year), but the diagnostic depth produces a baseline that makes every subsequent intervention more targeted.

Use Case 5: Thyroid Optimization

Best alternative: Paloma Health

Paloma Health focuses entirely on hypothyroidism and thyroid optimization. They test TSH, free T4, free T3, reverse T3, and thyroid antibodies as a standard panel, far more comprehensive than most primary care baselines.

The American Thyroid Association's 2014 guideline (updated position statements through 2023) supports combination T4/T3 therapy in patients who remain symptomatic on levothyroxine alone [8]. Paloma is one of the few telehealth platforms with explicit protocols for T3 add-on (liothyronine) when free T3 remains low on levothyroxine monotherapy. The monthly cost is approximately $75 plus lab fees.

1st Optimal vs. Alternatives: Direct Comparison Table

| Platform | Primary Strength | Avg. Monthly Cost | Insurance? | Peptides? | |---|---|---|---|---| | 1st Optimal | Broad performance/longevity protocols | $150, $350 | No | Yes | | Defy Medical | Men's TRT depth | $100, $200 | No | Limited | | Maximus | Low-cost men's TRT | $129, $149 | No | No | | Ro Body | GLP-1 + dietitian support | $99, $299 | Partial | No | | Found | GLP-1 + behavioral health | $79, $199 | Partial | No | | Midi Health | Women's menopause care | $95, $175 | Partial | No | | Alloy | Perimenopause HRT | $75, $90 | No | No | | AgelessRx | Conservative longevity Rx | $50, $150 | No | Limited | | Fountain Life | Diagnostics-first longevity | $3,500+/yr | No | Limited | | Paloma Health | Thyroid optimization | $75 + labs | No | No |

How to Choose: A Clinical Decision Framework

The right platform depends on your primary clinical problem, not on which brand markets most aggressively to your demographic.

Step 1: Name Your Primary Problem

Write down the one condition or goal that bothers you most. If you cannot name it in one sentence, start with a diagnostic workup rather than a treatment platform. Fountain Life or even a direct-pay functional medicine physician may serve you better than any telehealth subscription.

Step 2: Match Specialization to Severity

For low testosterone confirmed by two morning total-testosterone measurements below 300 ng/dL (the Endocrine Society threshold for considering therapy) [2], go with a TRT-specialist platform. For obesity with BMI above 30, or BMI above 27 with a metabolic comorbidity, go with a GLP-1 specialist. For perimenopausal symptoms, go with a menopause-certified practice.

Step 3: Evaluate Lab Protocols Before Signing Up

A platform's intake lab panel is a proxy for clinical rigor. Minimum acceptable labs for TRT include: total testosterone (two morning draws), free testosterone (equilibrium dialysis preferred), LH, FSH, SHBG, hematocrit, PSA (men over 40), and a metabolic panel. Minimum for GLP-1: HbA1c, fasting glucose, lipids, kidney function, and thyroid-stimulating hormone (to rule out medullary thyroid carcinoma risk factors) [3].

Step 4: Confirm Pharmacy Sourcing

Ask whether the pharmacy is 503A (patient-specific compounding) or 503B (outsourcing facility, FDA-registered, sterile manufacturing). For injectable peptides and compounded GLP-1, 503B sourcing is safer. The FDA's database of registered outsourcing facilities is publicly searchable [1].

What Real Patients Report About 1st Optimal

Patient-reported experiences collected from public forums (Reddit r/Testosterone, r/PeptidesDiscussion, and Trustpilot as of late 2024) suggest the following patterns:

Positive reports cluster around the breadth of the intake consultation, providers who engage with labs in detail, and the ability to discuss peptide stacks without being dismissed. Negative reports cluster around cost (some members report feeling upsold on add-on labs or compounds), response time for follow-up messages, and protocol changes that feel provider-driven rather than data-driven.

These patterns are not unique to 1st Optimal. They reflect tensions built into the cash-pay concierge model generally. A 2022 editorial in the Annals of Internal Medicine warned that direct-pay concierge practices risk creating financial incentives to over-test and over-prescribe because revenue depends on ongoing patient engagement rather than outcomes [9].

Specific Questions to Ask Any 1st Optimal Alternative Before Enrolling

Ask these directly in the intake call or through the platform's messaging system:

• Which licensed physician (name and state license number) will sign my prescriptions?
• What is the clinical rationale for each compound in the proposed protocol?
• Which 503B outsourcing facility supplies your injectable compounds?
• How often will labs be repeated, and who reviews them?
• What is the discontinuation protocol if I experience adverse effects?

A platform that answers all five questions clearly earns more clinical trust than one that deflects to marketing language.